logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10688146 B1

PDFFull Text
Date of Patent:
Jun. 23, 2020

Filed:

May. 21, 2018

Val et. zipp. extract as a treatment to overcome prostate problems

Applicant:

PT Dexa Medica, Tangerang Selatan, ID;

Inventors:

Asep Aripin, Karawang, ID;

Agung Heru Karsono, Jakarta Timur, ID;

Olivia Mayasari, Jakarta Utara, ID;

Priska Hardadi, Bekasi, ID;

James M. Sinambela, Bekasi, ID;

Raymond R. Tjandrawinata, Jakarta Selatan, ID;

Assignee:

PT Dexa Medica, Tangerang, ID;

Attorney:

Neifeld IP Law

Primary Examiner:

Terry A McKelvey

Assistant Examiner:

Norussell G Fiebig

Int. Cl.
CPC ...
A61K 36/9066 (2006.01); A61K 9/00 (2006.01); A23L 33/105 (2016.01); A23L 2/52 (2006.01); A61K 9/46 (2006.01); A61K 9/02 (2006.01); A61K 9/06 (2006.01); A61K 9/08 (2006.01); A61K 9/10 (2006.01); A61K 9/107 (2006.01);
U.S. Cl.
CPC ...
A61K 36/9066 (2013.01); A23L 2/52 (2013.01); A23L 33/105 (2016.08); A61K 9/0053 (2013.01); A61K 9/0095 (2013.01); A23V 2002/00 (2013.01); A61K 9/006 (2013.01); A61K 9/0007 (2013.01); A61K 9/0014 (2013.01); A61K 9/0019 (2013.01); A61K 9/0031 (2013.01); A61K 9/02 (2013.01); A61K 9/06 (2013.01); A61K 9/08 (2013.01); A61K 9/10 (2013.01); A61K 9/107 (2013.01); A61K 2236/00 (2013.01);
Abstract

A preparation comprises a herbal extract and/or fraction, and a pharmaceutical preparation includes extract ofVal. et Zipp., which has bioactivities in reducing expression levels of 5-alpha-reductase-1, androgen receptor, and PI3 in prostate cancer cells. The use of this present invention is directed to reduce prostate enlargement. Moreover, it also can be used to treat prostate cancer, lung cancer, and other diseases related to GPCR pathway.

Find Patent Forward Citations

Aripin, Asep. (2020). Val et. zipp. extract as a treatment to overcome prostate problems (U.S. Patent No. 10688146). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10688146

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…